The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

LTRN READ THE FULL LTRN RESEARCH REPORT Lantern Pharma, Inc (NASDAQ:LTRN) reports 2024 results highlighting several ...

Scientists have revealed how tiny swimming organisms—such as bacteria—are able to move faster when traveling as a group—and ...

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda can cut the time spent in ...

G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...

Acrivon has developed its AP3 Interactome, a proprietary, computational analytics platform driven by Generative ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Covered in ultra-plush faux fur, these double-strap sandals are a great deal. They're normally $27, but select colors are on ...

The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...

Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today reported its business highlights ...

Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council, highlights upcoming discussions on ...

Contributed commentary by Amanda Patterson, communications coordinator with Centerstone, on the benefits of sunshine.